Zivin; Robert A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zivin; Robert A..The latest application filed is for "topical application of 1-hydroxyl 3,5-bis(4'hydroxyl styryl)benzene".

Company Profile

0.9.11

Zivin; Robert A. - Miami FL US
Zivin; Robert A. - Lawrenceville NJ
Zivin; Robert A. - Cranbury NJ
Zivin; Robert A. - Skillman NJ
Zivin; Robert A. - Blue Bell PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Topical application of 1-hydroxyl-3,5-BIS(4'hydroxy styryl)benzene Grant 8,846,013 - Kaur , et al. September 30, 2	2014-09-30
Topical Application Of 1-hydroxyl-3,5-bis(4'hydroxyl Styryl)benzene App 20140004066 - Kaur; Simarna ; et al.	2014-01-02
Topical Application Of 1-hydroxyl 3,5-bis(4'hydroxyl Styryl)benzene App 20140005275 - Kaur; Simarna ; et al.	2014-01-02
Cdr-grafted Anti-tissue Factor Antibodies And Methods Of Use Thereof App 20100298544 - Joliffe; Linda K. ; et al.	2010-11-25
CDR-grafted anti-tissue factor antibodies and methods of use thereof Grant 7,777,018 - Joliffe , et al. August 17, 2	2010-08-17
CDR-grafted anti-tissue factor antibodies and methods of uses there of Grant 7,544,790 - Joliffe , et al. June 9, 2	2009-06-09
CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof App 20080226628 - Joliffe; Linda K. ; et al.	2008-09-18
Generation Of Animal Models App 20070266449 - Zivin; Robert A.	2007-11-15
CDR-grafted anti-tissue factor antibodies and methods of uses there of App 20070238869 - Joliffe; Linda K. ; et al.	2007-10-11
CDR-grafted anti-tissue factor antibodies and methods of use thereof Grant 7,235,380 - Joliffe , et al. June 26, 2	2007-06-26
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies App 20060292142 - Bluestone; Jeffrey A. ; et al.	2006-12-28
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies App 20060002933 - Bluestone; Jeffrey A. ; et al.	2006-01-05
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies App 20030108548 - Bluestone, Jeffrey A. ; et al.	2003-06-12
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies Grant 6,491,916 - Bluestone , et al. December 10, 2	2002-12-10
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies Grant 5,885,573 - Bluestone , et al. March 23, 1	1999-03-23
Agonist peptide dimers Grant 5,767,078 - Johnson , et al.	1998-06-16
Cardiac atrial peptides Grant 4,952,561 - Scolnick , et al. August 28, 1	1990-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.